 |
| Licensing Agreement | Privacy Policy © 2019 CCH Incorporated and its affiliates. All rights reserved. |
Title: FDA Regulation of Digital Health and Health IT Date: May 10, 2018 After May 10, 2018? Sign up for the On-Demand Replay! Time: 1:00 PM Eastern Daylight Time Duration: 1 hour |
Health Law Hot Topics Webinar Series Session Two: FDA Regulation of Digital Health and Health IT |
 |
 |
| Digital Health is growing at an extremely fast
rate and FDA is striving to encourage digital health innovation while
protecting the public health. Learn how
FDA regulates the wide range of digital health products and the initiatives the
agency has launched to keep pace with this field. |
This program is currently pending approval of CEU from The Compliance Certification Board (CCB)® . Registration requires a complete Name, Title, Organization, and a valid business Email Address. Wolters Kluwer Legal & Regulatory U.S. is pleased to partner with Above the Law for CLE accreditation.* Upon the conclusion of each webinar an informal certificate of completion will be issued by Wolters Kluwer Legal & Regulatory U.S. Attendees will also receive an official certificate via email from Above the Law's third party CLE provider, Marino Law. *CLE available for NY, NJ, and CA. A Uniform Certificate of Attendance for CLE credit will be issued for all other states. |
| CLE credits are only offered for live attendance and are complimentary. |
 |
Presenter: Stephanie Philbin Stephanie Philbin is a counsel in Goodwin’s Life Sciences practice and a member of its FDA group. Philbin concentrates her practice on Food and Drug Administration laws, advising medical device clients on regulatory and compliance issues. She also advises investors in FDA-regulated companies, including drug and biotech companies. |
 |